Medicinova Granted Notice of Allowance for New patents in NASH, NAFLD and ALS
Medicinova (NASDAQ: MNOV), a Company developing small molecule therapeutics, has received notice of allowances for grant of new patents for MN-166 (ibudilast) for...
Coverage
- All
- Beauty
- Biotechnology
- Cannabis
- Communications
- Education
- Energy
- Entertainment
- Environment
- ETFs
- Finance
- Fitness
- Food and Beverage
- Healthcare
- Hospitality
- Insider Trading
- Investing Ideas
- Macro
- Market Insight
- Miscellaneous
- Power
- Real Estate
- Retail
- Sectors
- Security
- Startups
- Technologies
- Trending
- Uncategorized
Provention Bio’s for PRV-031 (teplizumab) granted PRIME Designation by the EMA
Provention Bio (NASDAQ: PRVB), a clinical-stage biopharmaceutical Company, announced the grant of a PRIority MEdicines (PRIME) designation by the European Medicines Agency (EMA),...
Hola Mexico! Recreational Cannabis likely to be legalized in the Country Soon
The Global legal marijuana market is likely to reach over USD 66.3 billion by the end of 2025, as per a report by...
dynaCERT signs a strategic agreement with MOSOLF Germany for distribution of its HydraGENä Technology products
dynaCERT (OTCQB: DYFSF), a Company dealing in transportable hydrogen generator aftermarket products, announced the signing of a strategic agreement with MOSOLF group of...
5 Companies Looking Beyond Enzyme Replacement Therapy for Treatment of Pompe Disease
Pompe disease is characterized by the build-up of complex sugars named glycogens in the body’s cell, due to the lack of an enzyme...
Paratek withdraws European Marketing Authorization for Nuzyra
Paratek Pharmaceuticals (NASDAQ: PRTK), a commercial-stage biopharmaceutical Company, announced the withdrawal of its submission to the European Medicines Agency (EMA), for the grant...
HLS Therapeutics granted medical device license for One WBC System by Health Canada
HLS Therapeutics Inc (OTCPINK: HLTRF), a specialty pharmaceutical Company developing solutions for the treatment of central nervous system and cardiovascular disorders, announced the...
Kandi Technologies Charging Ahead in the Electric Vehicles Market
Kandi Technologies Group Inc (NASDAQ: KNDI), a Company engaged in the development and manufacturing of vehicular products, announced that it has successfully executed...
Adverum Biotechnologies Presents Additional Clinical Data From its Phase I Intravitreal Gene Therapy for Wet AMD
Adverum Biotechnologies (NASDAQ: ADVM), a clinical-stage Company focused on developing therapeutics for ocular and rare diseases through gene therapy, released additional clinical data...
